Orthofix Medical Inc.
OFIX
$12.31
$1.4613.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.85% | 7.08% | 17.32% | 28.94% | 43.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.85% | 7.08% | 17.32% | 28.94% | 43.54% |
| Cost of Revenue | 4.56% | -1.09% | 6.05% | 25.65% | 56.04% |
| Gross Profit | 6.48% | 11.28% | 23.22% | 30.55% | 38.12% |
| SG&A Expenses | 2.76% | 0.40% | 9.41% | 19.44% | 37.46% |
| Depreciation & Amortization | -18.31% | 13.28% | 28.19% | 34.89% | 66.73% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.26% | -0.56% | 7.85% | 20.62% | 41.65% |
| Operating Income | 23.58% | 42.86% | 39.41% | 22.51% | -29.36% |
| Income Before Tax | -14.02% | 16.68% | 13.02% | -2.93% | -67.73% |
| Income Tax Expenses | -24.49% | -21.87% | 5.44% | -28.43% | 14.44% |
| Earnings from Continuing Operations | -13.12% | 16.78% | 12.66% | -1.99% | -65.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.12% | 16.78% | 12.66% | -1.99% | -65.92% |
| EBIT | 23.58% | 42.86% | 39.41% | 22.51% | -29.36% |
| EBITDA | 134.01% | 98.59% | 81.12% | 62.19% | 1.03% |
| EPS Basic | -8.92% | 20.46% | 19.53% | 12.50% | -37.83% |
| Normalized Basic EPS | 5.14% | 22.51% | 28.99% | 19.76% | -9.15% |
| EPS Diluted | -8.94% | 20.54% | 19.61% | 12.60% | -37.33% |
| Normalized Diluted EPS | 5.14% | 22.51% | 28.99% | 19.76% | -9.21% |
| Average Basic Shares Outstanding | 3.59% | 4.02% | 16.63% | 33.27% | 55.17% |
| Average Diluted Shares Outstanding | 3.59% | 4.02% | 16.63% | 33.27% | 55.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |